Oregon Freeze Dry Opens $7.5 Million Biopharma Facility

The new facility in Albany, Ore., will support biopharmaceutical development and lyophilization services.

Oregon Freeze Dry (OFD), a lyophilization and freeze-drying company, opened a new biopharmaceutical development and clinical facility in Albany, Ore., on July 25, 2022. According to a company press release, the $7.5 million facility is designed to support the development of traditional pharmaceutical active ingredients, combination products, and medical devices, as well as support lyophilization process development.

The Albany facility will also host lyophilization process development and clinical trials, and features environmental controls that can support development of oral drugs. The Albany facility is OFD’s fifth facility in the United States and is set to add at least six new positions to a staff of more than 450.

“Our new facility supports the vision of a world where vaccines and medications can bypass a syringe and be administered orally, increasing access to life-changing medicine around the world,” said Joe Folds, president and CEO, OFD, in the release. “We’re ready and eager to collaborate with pharmaceutical companies and support advances in microbial therapeutics, immunotherapy, and cell and gene therapy.”

Source: Oregon Freeze Drying